Quantcast
  Free Report!
  The Only 3 Options Strategies You'll Ever Need   
 


Win Over $12,000
Predicting the Direction of a Stock!


Stocks

Trading Ideas

Short Term
Long Term
All Trading Ideas


Trading Lessons

Strategies
Courses
Interviews
Glossary
All Trading Lessons


Daily Stock Setups

Connors Daily Battle Plan
Haggerty Professional
Kaltbaum Intra-day Set-ups
Short Term PowerRatings
Long Term PowerRatings
TM Indicators


Trading News

Markets Updates
Technical Alerts
Breaking News


PowerRatings

Short Term
Long Term
Charts


Indicators

Stocks
Market Bias


Quotes

Markets
Stocks
Charts
Level II
Historical Data
Options


Trading Contests

Up or Down


 
New Mexico Veterans Call for early lung cancer screening using Biomoda technology
Tuesday, January 22, 2008; Posted: 12:16 PM
Jan 22, 2008 (M2 EQUITYBITES via COMTEX) -- BUSRF | news | PowerRating |
Free Report!
Double, Triple or Even Quadruple Your Returns Using ETFs
 
 
 

PR Charts -- Biomoda (OTCBB:BMOD), an Albuquerque biomedical company that has developed a non-invasive test for early detection of lung cancer, declared on 21 January that busloads of New Mexico veterans will meet state legislators on 29 January as part of "Veterans Day" in Santa Fe to push for USD1.3m in funding of an early lung cancer screening programme for veterans.

The company said the programme will utilise its lung cancer screening technology and is being conducted by New Mexico Tech University. The company claimed hundreds of veterans and their families representing the Veterans of Foreign Wars (VFW), American Legion, Am-Vets, Disabled American Veterans, Black Veterans Association of New Mexico, Jewish War Veterans, Gold Star Mothers and the Blue Star Mothers will board buses in Taos, Espanola and Albuquerque to participate in the day's ceremonies, including meetings to push their legislative agenda at the Round House. According to Biomoda, its patented technology, a non-invasive cytology based assay, is designed for cancer screening of large populations at a reasonable cost. Current diagnostic methods for lung cancer, including CT scans and X-rays, reportedly often detect the disease only at more advanced stages and are relatively expensive.

Comments on this story may be sent to admin@m2.com

Morning Coffee with TradingMarkets -- Free Newsletter


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Stocks RSS Submit to del.icio.us Submit to Digg it



Most Popular


  As of 2 am ET
  Updates every 2 hrs

NameSymbolPR
Western Refining Inc    WNR8
Renal Care Group Inc    RCI8
Rait Financial Trust    RAS8
Penn Va Resource Partners Lp    PVR8
Netflix Inc    NFLX8
More Top Rated Stocks >>
Free Trial
Short Term   Long Term   PowerRatings Charts
PREMIER SPONSORED LINKS
TRADE CENTER
 
 
 

The TradingMarkets Directory
Stocks
Quotes
Charts
How to Trade
Commentary and Analysis
PowerRatings
Training Classes
Tools
Stock Scanner
Daily Market Bias

Options
Quotes
Charts
How to Trade
Commentary and Analysis

Forex
How to Trade
Forex Momentum Index
Pivots

E-mini/Futures
Quotes
Charts
How to Trade
Daily Market Bias

How to Trade
Stocks
Options
Forex
E-mini/Futures
Glossary

Tools
Short Term PowerRatings
Long Term PowerRatings
Stock Screener
Quotes & Charts
Stock Indicators
Market bias Indicators

PowerRatings
Short Term PowerRatings
Long Term PowerRatings
Industry PowerRatings
PowerRatings Charts
Training Classes
PowerRatings Strategies
Search PowerRatings

Trading Contests
Up or Down Stock Contest
#1 - Win $1000 every month

Up or Down Forex Contest -
Win $1000 every month


Premium Subscription Services
Short Term PowerRatings Free Trial
Long Term PowerRatings Free Trial
TradingMarkets Subscription Free Trial
Daily Battle Plan Free Trial
Gary Kaltbaum - Intraday Breaking Alerts Free Trial
Kevin Haggerty Professional Trading Service Free Trial
Forex Force with Mark Whistler Free Trial

RELATED SITES
Nothing but forex





All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.